Senior Medical Director, Transplant / Immunology at Astellas Pharma US
United States
Program Director, Institutional Leader, Basic Science and Clinical Investigator, and Accomplished Multi-Organ Transplant Surgeon with extensive practical knowledge of clinical transplant therapeutics, immunology, inflammation, and end organ disease. Proven ability to align institutional stakeholders to achieve programmatic goals and research initiatives. Prolific educator who has organized and presided over transplant symposia and Continuing Medical Education efforts for...
Program Director, Institutional Leader, Basic Science and Clinical Investigator, and Accomplished Multi-Organ Transplant Surgeon with extensive practical knowledge of clinical transplant therapeutics, immunology, inflammation, and end organ disease. Proven ability to align institutional stakeholders to achieve programmatic goals and research initiatives. Prolific educator who has organized and presided over transplant symposia and Continuing Medical Education efforts for hundreds in the community. Possesses strong aptitude for original as well as collaborative-based scientific investigation at all stages of the research process. • In my recent role as Surgical Director, I overcame mission-critical challenges to dramatically improve center outcomes. Under my direction, 100% patient and graft survival over a period of 24 months, transplant volumes and surgical visits increased by 60%, referrals went up by 30%, and the number of patients listed for transplant rose 50%. • Key Opinion Leader sought after by Pfizer and Ferring Research to develop investigator-initated studies • My career trajectory reflects the ability to empower people with diverse interests to work together. Facilitated the turn-around of two separate transplant programs using my ability to form, maintain, and lead cross-functional, multi-disciplinary teams. • Helped launch the multi-organ transplant effort at a major academic medical center while simultaneously re-establishing program viability for a neighboring transplant program facing closure by regulatory agencies. • Built a comprehensive research infrastructure from the ground up and conceived new animal models, helped found a start up company, and translated a drug discovery effort to a development agreement with a 3rd party licensee. • Authored 30 manuscripts and 22 abstracts in the past 5 years, initiated and chaired educational symposia, and served as an expert faculty / consultant to industry.Associate Professor and Surgical Director, Kidney Transplant Progam @ •Strengthened organizational links between medical and surgical sub-specialties, nursing, allied health partners, referral sources, and administration at all levels •Lead efforts to streamline program efficiency and improve productivity in collaboration with multi-specialty partners • Reformulated roles of team members, leveraging organizational and problem-solving skills • Instituted novel quality improvement initiative that contributed to gains in programmatic outcomes and overall team dynamics •Net result: 60% increase in surgical visits, 30% increase in referrals, 50% increase in wait list additions, and 60% increase in transplants performed. •Achieved 100% graft and patient survival for 24 months •Inaugurated and co-chaired Transplant & Dialysis Update, UTSW’s continuing education effort for community physicians. From October 2011 to April 2014 (2 years 7 months) Co-Chief Medical Officer @ • Partnered with other founders to incorporate interests and raise start-up funds. Performed original pre-clinical research • Provided guidance on clinical development for therapeutic area, designed clinical trial, and authored SBIR grant • Parlayed drug discovery efforts to development accord with 3rd party licensee. From September 2011 to April 2014 (2 years 8 months) Assistant Professor @ • Multi-organ transplant program inception. Responsible for clinical care, operative responsibility, organ recovery, education of residents and staff • Built comprehensive translational research effort from the ground up. • Characterized new animal model by investigating the murine transcriptome in the setting of hepatorenal syndrome • Described the only known technique to measure portal pressures in awake, conscious animals. Tested compounds for Ferring Research to lower portal pressures • Pioneered and published on the novel pharmaceutical treatment of steatohepatitis in animals. Patent pending for work • Organized the Liver Oncology Program at the NCI-designated Huntsman Cancer Center • Authored study protocol and served as PI for institutional trial facilitating liver transplantation in patients with cholangiocarcinoma. Culminated in multi-center trial published in Gastroenterology • Described and published new method for diagnosing cholangiocarcinoma • Designed database for tracking outcomes, tissue specimens, and clinical data for transplant and hepatobiliary patients in cooperation with the bioinformatics department at the Huntsman Cancer Institute • Instituted and coordinated weekly Transplant Grand Rounds visiting speaker program • Expert Faculty, Pfizer Inc. • Conducted investigator-initiated trial examining tissue levels of anidulafungin in transplant patients for Pfizer • Assembled program to teach liver transplantation to surgical residents in a swine model • Officially mentored over 20 students and trainees in a 1:1 capacity • Exemplary resident evaluations, consistently receiving high marks for teaching, bedside manner, and resident interactions • Consultant to Myriad Genetics From September 2005 to October 2011 (6 years 2 months) Greater Salt Lake City AreaAdjunct Faculty @ Facilitated improved surgical outcomes, provided administrative oversight, and supplied clinical expertise to ensure established kidney transplant program emerged on solid footing after a period of CMS-mandated closure From December 2008 to September 2010 (1 year 10 months) Bachelor of Science (BS), Biochemistry @ University of Illinois at Urbana-Champaign From 1988 to 1992 Doctor of Medicine (MD), Medicine, Graduated with Honors @ University of Illinois at Chicago College of Medicine From 1992 to 1996 Resident in General Surgery @ The University of Texas Southwestern Medical Center at Dallas From 1996 to 2003 NIH Research Fellowship, Burns, Trauma, Critical Care @ The University of Texas Southwestern Medical School From 1999 to 2001 Fellow in Abdominal Transplantation @ Mayo Clinic, Rochester From 2003 to 2005 Jason FACS is skilled in: Surgery, Healthcare, Hospitals, Matrix Leadership, Medical Education, Healthcare Management, Kidney Transplant, Liver Transplant, Liver Disease, Kidney Disease, Molecular Biology, Clinical Research, Clinical Trials, Pancreas Transplant, Organ Donation
UT Southwestern Medical Center at Dallas
Associate Professor and Surgical Director, Kidney Transplant Progam
October 2011 to April 2014
Lone Star Thiotherapies
Co-Chief Medical Officer
September 2011 to April 2014
University of Utah Hospitals and Clinics
Assistant Professor
September 2005 to October 2011
Greater Salt Lake City Area
University of Southern Nevada, Las Vegas
Adjunct Faculty
December 2008 to September 2010
University of Illinois at Urbana-Champaign
Bachelor of Science (BS) Biochemistry
1988 to 1992
University of Illinois at Chicago College of Medicine
Doctor of Medicine (MD) Medicine Graduated with Honors
1992 to 1996
The University of Texas Southwestern Medical Center at Dallas
Resident in General Surgery
1996 to 2003
The University of Texas Southwestern Medical School
NIH Research Fellowship Burns Trauma Critical Care
1999 to 2001
Mayo Clinic, Rochester
Fellow in Abdominal Transplantation
2003 to 2005
•Strengthened organizational links between medical and surgical sub-specialties, nursing, allied health partners, referral sources, and administration at all levels •Lead efforts to streamline program efficiency and improve productivity in collaboration with multi-specialty partners • Reformulated roles of team members, leveraging organizational and problem-solving skills • Instituted novel quality improvement initiative that contributed to gains in programmatic outcomes... •Strengthened organizational links between medical and surgical sub-specialties, nursing, allied health partners, referral sources, and administration at all levels •Lead efforts to streamline program efficiency and improve productivity in collaboration with multi-specialty partners • Reformulated roles of team members, leveraging organizational and problem-solving skills • Instituted novel quality improvement initiative that contributed to gains in programmatic outcomes and overall team dynamics •Net result: 60% increase in surgical visits, 30% increase in referrals, 50% increase in wait list additions, and 60% increase in transplants performed. •Achieved 100% graft and patient survival for 24 months •Inaugurated and co-chaired Transplant & Dialysis Update, UTSW’s continuing education effort for community physicians.
What company does Jason FACS work for?
Jason FACS works for UT Southwestern Medical Center at Dallas
What is Jason FACS's role at UT Southwestern Medical Center at Dallas?
Jason FACS is Associate Professor and Surgical Director, Kidney Transplant Progam
What industry does Jason FACS work in?
Jason FACS works in the Pharmaceuticals industry.
Issued by American Transplant Congress · 2009
Issued by American Transplant Congress · 2012
Issued by The Liver Meeting (American Association for the Study of Liver Disease) · 2013
Enjoy unlimited access and discover candidates outside of LinkedIn
One billion email addresses and counting
Everything you need to engage with more prospects.
ContactOut is used by
76% of Fortune 500 companies
Jason FACS's Social Media Links
www.us.ast...